| Literature DB >> 30455625 |
Christopher D Rowley1, Sarah J Tabrizi2, Rachael I Scahill2, Blair R Leavitt3, Raymund A C Roos4, Alexandra Durr5,6, Nicholas A Bock7.
Abstract
Huntington's disease (HD) is a genetic neurodegenerative disorder that is characterized by neuronal cell death. Although medium spiny neurons in the striatum are predominantly affected, other brain regions including the cerebral cortex also degenerate. Previous structural imaging studies have reported decreases in cortical thickness in HD. Here we aimed to further investigate changes in cortical tissue composition in vivo in HD using standard clinical T1-weighted (T1W) and T2-weighted (T2W) magnetic resonance images (MRIs). 326 subjects from the TRACK-HD dataset representing healthy controls and four stages of HD progression were analyzed. The intracortical T1W/T2W intensity was sampled in the middle depth of the cortex over 82 regions across the cortex. While these previously collected images were not optimized for intracortical analysis, we found a significant increase in T1W/T2W intensity (p < 0.05 Bonferroni-Holm corrected) beginning with HD diagnosis. Increases in ratio intensity were found in the insula, which then spread to ventrolateral frontal cortex, superior temporal gyrus, medial temporal gyral pole, and cuneus with progression into the most advanced HD group studied. Mirroring past histological reports, this increase in the ratio image intensity may reflect disease-related increases in myelin and/or iron in the cortex. These findings suggest that future imaging studies are warranted with imaging optimized to more sensitively and specifically assess which features of cortical tissue composition are abnormal in HD to better characterize disease progression.Entities:
Keywords: Huntington’s disease; MRI; cerebral cortex; myelin; neurodegeneration
Year: 2018 PMID: 30455625 PMCID: PMC6230564 DOI: 10.3389/fnins.2018.00805
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Demographics for the participants used from the baseline TRACK-HD dataset.
| Controls ( | PreHD | HD | |||||
|---|---|---|---|---|---|---|---|
| PreHD-A ( | PreHD-B ( | Combined ( | HD Stage 1 ( | HD Stage 2 ( | Combined ( | ||
| Age (years) | 46.1 (10.5) | 40.6 (8.7) | 39.6 (8.8) | 40.1 (8.9) | 47.1 (10.2) | 50.9 (8.8) | 48.6 (9.8) |
| Women | 60 (54%) | 30 (56%) | 29 (57%) | 59 (56%) | 40 (59%) | 19 (46%) | 59 (54%) |
| Disease-Burden score | N/A | 259.8 (29.0) | 335.4 (30.2) | 296.6 (48.2) | 357.8 (74.5) | 397.2 (69.7) | 372.7 (75.3) |
| Site #1 | 25 | 14 | 11 | 25 | 15 | 12 | 27 |
| Site #2 | 29 | 14 | 16 | 30 | 19 | 11 | 30 |
| Site #3 | 29 | 13 | 15 | 28 | 23 | 4 | 27 |
| Site #4 | 29 | 13 | 9 | 21 | 11 | 14 | 25 |
FIGURE 1Middle depth T1W/T2W ratio signal for each study group. The effects of age and imaging site on the ratio signal were regressed out on a per-vertex basis for each subject before calculation of the average.
FIGURE 2T1W/T2W ratio changes in HD. Coefficients from the intracortical signal analysis are mapped onto the cortex (left), illustrating the difference in ratio signal relative to controls with effects of age and imaging site regressed out of the signal. Uncorrected p-values generated for each group from the linear models are mapped onto the cortex for each region to visualize trends in changing intracortical signal (middle). Changes in intracortical signal that are significant following multiple comparison correction are found in HD Stage 1 and 2 (right).